Clinical Trials Browser

Phase 1/2 × enadenotucirev × Gastrointestinal × Clear all

NCT02028442 2020-03-12

EVOLVE

Phase 1/2 Completed

GastrointestinalGenitourinary

Urinary Bladder Neoplasms, Colorectal Neoplasms